The University of Chicago Header Logo

Connection

Anjana Pillai to Combined Modality Therapy

Back to Details
This is a "connection" page, showing publications Anjana Pillai has written about Combined Modality Therapy.
Anjana Pillai
Connection Strength
0.040
Combined Modality Therapy
  1. Phase 1 Randomized Trial of Stereotactic Body Radiation Therapy Followed by Nivolumab plus Ipilimumab or Nivolumab Alone in Advanced/Unresectable Hepatocellular Carcinoma. Int J Radiat Oncol Biol Phys. 2023 01 01; 115(1):202-213.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.